H. pylori in the pathogenesis of duodenal ulcer: interaction between duodenal acid load, bile, and H. pylori.
OBJECTIVE
Helicobacter pylori (H. pylori) growth is inhibited by bile yet it can grow in the duodenal bulb and cause ulcer disease. The aim of this study was to test the effect of bile on H. pylori viability and growth and to determine whether acidification of bile reduces its inhibitory activity.


METHODS
Fresh human bile was collected at laparotomy and tested for inhibitory activity of H. pylori using broth dilution assays. Six clinical isolates of H. pylori obtained from patients with duodenal ulcer were used for each experiment. The bile was diluted from 1:3 to 1:192; its inhibitory effect on H. pylori was tested before and after acidification, treatment with cholestyramine, or chloroform. Bile was acidified to a pH of 2-6, centrifuged at 8000 rpm for 20 min to remove precipitated bile acids, and the supernatant pH readjusted. Controls included BHI broth without bile (positive control) and bile that was acidified to pH 2 and neutralized without centrifugation.


RESULTS
Human bile inhibited H. pylori growth in a dose dependent manner. Growth of all strains was supported for all strains only at a dilution of 1:192. In contrast, after acidification to pH < or =5 and centrifugation to remove precipitated bile acids, all strains grew at a bile dilution of 1:12. Neither chloroform extraction of lipids, nor acidification without centrifugation removed the inhibitory action of bile. In contrast, cholestyramine sequestration of bile acids completely removed all inhibitory activity.


CONCLUSIONS
The duodenal acid load may be the critical factor to explain the ability of H. pylori to colonize the duodenal bulb by precipitating glycine-conjugated bile salts. The combination of a high duodenal acid load and H. pylori infection is likely the critical event in the pathogenesis of H. pylori-related duodenal ulcer disease.
Graham
D Y
DY
Department of Medicine, Veterans Affairs Medical Center, Houston, Texas 77030, USA.
Osato
M S
MS
D001646:Bile / Q000502:physiology*; D001647:Bile Acids and Salts / Q000494:pharmacology / Q000502:physiology; D002792:Cholestyramine Resin / Q000494:pharmacology; D004381:Duodenal Ulcer / Q000382:microbiology* / Q000503:physiopathology; D004386:Duodenum / Q000378:metabolism / Q000382:microbiology*; D016481:Helicobacter Infections / Q000382:microbiology* / Q000503:physiopathology; D016480:Helicobacter pylori / Q000254:growth & development*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques
D001647:Bile Acids and Salts; D002792:Cholestyramine Resin